Calycosin Inhibit PANoptosis and Alleviate Brain Damage: A Bioinformatics and Experimental Verification Approach
Huiyan An,
No information about this author
Chongyu Shao,
No information about this author
Yu He
No information about this author
et al.
ACS Chemical Neuroscience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 29, 2025
PANoptosis
is
a
newly
identified
form
of
cell
death
that
encompasses
pyroptosis,
apoptosis,
and
necroptosis.
Numerous
studies
have
highlighted
the
significance
in
brain
ischemia-reperfusion
(I/R)
injury.
Calycosin,
natural
product
with
diverse
biological
activities,
has
demonstrated
significant
reduction
neuronal
caused
by
ischemic
injury
modulating
multiple
pathways.
In
order
to
investigate
potential
mechanisms
underlying
neuroprotective
role
calycosin
alleviating
PANoptosis-induced
damage
stroke
therapy,
we
used
mouse
hippocampal
line
HT22
stimulate
ischemia
vitro
through
Oxygen
Glucose
Deprivation/Reperfusion
(OGD/R)
established
molecular
docking
assess
binding
affinity
Calycosin
key
targets
dynamics
simulations
(MDS)
study
stability
ligand-protein
complex.
The
results
demonstrate
could
improve
growth
HT22,
leading
enhanced
viability,
reduced
lactate
dehydrogenase
leakage,
decreased
apoptosis
after
OGD/R.
It
also
regulated
expression
PANoptosis-related
genes
such
as
NLRP3,
GSDMD,
MLKL,
RIPK1
increased
Bcl-2/Bax
ratio,
effectively
reducing
cellular
providing
protection.
Molecular
MDS
strong
activity
between
targets.
Furthermore,
successfully
passed
drug
similarity
(DS)
evaluation
exhibited
favorable
absorption,
distribution,
metabolism,
excretion,
toxicity
(ADMET)
properties
activity.
conclusion,
alleviate
inhibiting
PANoptosis,
inflammation
improving
Thus,
it
serve
therapy
for
stroke.
Language: Английский
Identification of novel inhibitors targeting Mycobacterium abscessus InhA through virtual screening, docking, and molecular dynamic simulations
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 14, 2025
Language: Английский
Structure-guided virtual screening reveals phytoconstituents as potent cathepsin B inhibitors: Implications for cancer, traumatic brain injury, and Alzheimer’s disease
Frontiers in Molecular Biosciences,
Journal Year:
2025,
Volume and Issue:
12
Published: April 16, 2025
Cathepsin
B
(CathB)
is
a
lysosomal
cysteine
protease
involved
in
various
pathological
and
physiological
processes
becoming
an
attractive
target
for
drug
intervention
complex
diseases
like
cancer,
traumatic
brain
injury
(TBI)
Alzheimer's
disease
(AD).
The
aberrant
expression
of
CathB
drives
tumor
invasiveness
metastasis
exacerbates
neurodegeneration
behavioral
deficits
AD
TBI.
However,
current
inhibitors
lack
clinical
translation
due
to
poor
selectivity,
bioavailability,
or
toxicity,
necessitating
novel
therapeutic
candidates.
To
address
this
gap,
silico
screening
was
conducted
through
the
structure-guided
virtual
with
IMPPAT
2
phytochemical
library
potential
inhibitors.
Using
control
inhibitor
CA-074Me
as
benchmark,
two
phytoconstituents,
Nicandrenone
Picrasidine
M,
emerged
superior
binding
affinities,
ligand
efficiency,
robust
interactions
active
site
residues
CathB.
These
molecules
were
further
validated
molecular
dynamics
(MD)
simulations,
which
supported
their
ability
bind
stably
pocket
thus
likely
hold
durable
inhibitory
activity.
Remarkably,
these
phytoconstituents
exhibited
favorable
pharmacokinetic
ADMET
profiles,
validate
lead
compounds.
study
showed
that
bioactive
compounds
could
be
developed
new
inhibitors,
opening
frontier
use
management
such
TBI,
AD.
Language: Английский
Investigating the potential compounds of Kalanchoe pinnata plant for the treatment of Inflammation utilizing molecular docking and molecular dynamic simulation approach
S. M. Istiaque Hamim,
No information about this author
Miah Roney,
No information about this author
Md. Nazim Uddin
No information about this author
et al.
Published: April 1, 2025
Language: Английский
Discovery and Characterization of Two Selective Inhibitors for a Mu-Class Glutathione S-Transferase of 25 kDa from Taenia solium Using Computational and Bioinformatics Tools
César Sánchez-Juárez,
No information about this author
Roberto Flores‐López,
No information about this author
Leonor Sánchez‐Pérez
No information about this author
et al.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
15(1), P. 7 - 7
Published: Dec. 25, 2024
Glutathione
S-transferases
(GSTs)
are
promising
pharmacological
targets
for
developing
antiparasitic
agents
against
helminths,
as
they
play
a
key
role
in
detoxifying
cytotoxic
xenobiotics
and
managing
oxidative
stress.
Inhibiting
GST
activity
can
compromise
parasite
viability.
This
study
reports
the
successful
identification
of
two
selective
inhibitors
mu-class
glutathione
S-transferase
25
kDa
(Ts25GST)
from
Taenia
solium,
named
i11
i15,
using
computationally
guided
approach.
The
workflow
involved
modeling
refining
3D
structure
sequence
AlphaFold
algorithm
all-atom
molecular
dynamics
simulations
with
an
explicit
solvent.
Representative
structures
these
putative
binding
site
low
conservation
relative
to
human
GSTs,
identified
via
SILCS
methodology,
were
employed
virtual
screening
through
ensemble
docking
commercial
compound
library.
compounds
found
reduce
enzyme's
by
50-70%
under
assay
conditions,
while
showing
reduction
only
30-35%
GSTM1,
demonstrating
selectivity
Ts25GST.
Notable,
displayed
competitive
inhibition
CDNB,
i15
exhibited
non-competitive
type.
Language: Английский